Cargando…

Effects of a CB(2) Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia

BACKGROUND AND OBJECTIVES: Neuroinflammation is closely associated with various diseases including neuropathic pain. Microglia are immune cells in the central nervous system which are the main players of immunity and inflammation. Since microglia are activated by nerve injury, and they produce proin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yaliang, Wolk, Barbara, Kendall, Debra A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276972/ https://www.ncbi.nlm.nih.gov/pubmed/34263256 http://dx.doi.org/10.33696/signaling.2.038

Ejemplares similares

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Unravelling Regioselectivity of Leuconostoc citreum ABK-1 Alternansucrase by Acceptor Site Engineering
por: Wangpaiboon, Karan, et al.
Publicado: (2021)

Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
por: Scott, Caitlin E., et al.
Publicado: (2015)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System
por: Fernández-García, Laura, et al.
Publicado: (2018)

Effects of pro‐inflammatory cytokines on cannabinoid CB (1) and CB (2) receptors in immune cells
por: Jean‐Gilles, L., et al.
Publicado: (2015)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
por: Capozzi, Antonella, et al.
Publicado: (2021)

MasABK Proteins Interact with Proteins of the Type IV Pilin System to Affect Social Motility of Myxococcus xanthus
por: Fremgen, Sarah, et al.
Publicado: (2013)

Cannabinoid 1 (CB(1)) receptor arrestin subtype‐selectivity and phosphorylation dependence
por: Manning, Jamie J., et al.
Publicado: (2022)

CB2 Receptor in Microglia: The Guardian of Self-Control
por: Komorowska-Müller, Joanna Agnieszka, et al.
Publicado: (2020)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

An α-1,6-and α-1,3-linked glucan produced by Leuconostoc citreum ABK-1 alternansucrase with nanoparticle and film-forming properties
por: Wangpaiboon, Karan, et al.
Publicado: (2018)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

Cannabinoid receptor subtype 2 (CB(2)R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells
por: Huang, Zebing, et al.
Publicado: (2016)

Diagnostico de operación del sistema de compresión de gas natural del complejo ABK-A de la sonda Campeche /
por: Carballo Guerrero, Mauro Eduardo
Publicado: (2001)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke
por: Yu, Seong-Jin, et al.
Publicado: (2015)

Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol
por: Ge, Haixia, et al.
Publicado: (2023)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2021)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Coupling of CB-2 and CB-1
por: Ansaldo
Publicado: (2003)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012)

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
por: Capozzi, Antonella, et al.
Publicado: (2018)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
por: Gado, Francesca, et al.
Publicado: (2022)

Inspección no destructiva a ductos ascendentes 36 a gasoducto NH-A hacia ABK-A para la evaluación de desgaste del material base.
por: Martínez García, José Antonio
Publicado: (1997)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
por: Zhu, Yanjing, et al.
Publicado: (2023)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
por: Liu, Qing-Rong, et al.
Publicado: (2020)

A rationally designed JAZ subtype-selective agonist of jasmonate perception
por: Takaoka, Yousuke, et al.
Publicado: (2018)

Effects of the cannabinoid CB(1) agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
por: Berger, Joel I., et al.
Publicado: (2017)

ATF5 Attenuates the Secretion of Pro-Inflammatory Cytokines in Activated Microglia
por: Zhu, Jiebo, et al.
Publicado: (2023)

The protective effect of the TSPO ligands 2,4-Di-Cl-MGV-1, CB86, and CB204 against LPS-induced M1 pro-inflammatory activation of microglia
por: Monga, Sheelu, et al.
Publicado: (2020)

Effects of WIN 55,212-2 (a non-selective cannabinoid CB(1) and CB(2) receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model
por: Florek-Luszczki, Magdalena, et al.
Publicado: (2014)

Unloading of CB-2 at Point 5
por: L. Veillet
Publicado: (2004)

Analgesic effect of a mixed T-type channel inhibitor/CB(2) receptor agonist
por: Gadotti, Vinicius M, et al.
Publicado: (2013)

CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
por: Parlar, Ali, et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_967pdr0pjsmms1kmo6o0k3b2i7